Erste Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $421K | Hold |
35,700
| – | – | ﹤0.01% | 654 |
|
|
2025
Q1 | $274K | Hold |
35,700
| – | – | ﹤0.01% | 464 |
|
|
2024
Q4 | $225K | Hold |
35,700
| – | – | ﹤0.01% | 481 |
|
|
2024
Q3 | $179K | Hold |
35,700
| – | – | ﹤0.01% | 483 |
|
|
2024
Q2 | $124K | Hold |
35,700
| – | – | ﹤0.01% | 487 |
|
|
2024
Q1 | $103K | Hold |
35,700
| – | – | ﹤0.01% | 490 |
|
|
2023
Q4 | $190K | Hold |
35,700
| – | – | ﹤0.01% | 483 |
|
|
2023
Q3 | $198K | Hold |
35,700
| – | – | ﹤0.01% | 476 |
|
|
2023
Q2 | $243K | Hold |
35,700
| – | – | ﹤0.01% | 476 |
|
|
2023
Q1 | $301K | Hold |
35,700
| – | – | 0.01% | 473 |
|
|
2022
Q4 | $270K | Hold |
35,700
| – | – | 0.01% | 467 |
|
|
2022
Q3 | $245K | Hold |
35,700
| – | – | 0.01% | 482 |
|
|
2022
Q2 | $293K | Hold |
35,700
| – | – | 0.01% | 482 |
|
|
2022
Q1 | $495K | Hold |
35,700
| – | – | 0.01% | 437 |
|
|
2021
Q4 | $937K | Hold |
35,700
| – | – | 0.02% | 361 |
|
|
2021
Q3 | $1.16M | Hold |
35,700
| – | – | 0.02% | 327 |
|
|
2021
Q2 | $1.51M | Hold |
35,700
| – | – | 0.03% | 315 |
|
|
2021
Q1 | $1.34M | Hold |
35,700
| – | – | 0.03% | 315 |
|
|
2020
Q4 | $2.12M | Sell |
35,700
-6,300
| -15% | -$374K | 0.06% | 258 |
|
|
2020
Q3 | $2.02M | Hold |
42,000
| – | – | 0.07% | 245 |
|
|
2020
Q2 | $1.93M | Hold |
42,000
| – | – | 0.08% | 236 |
|
|
2020
Q1 | $1.14M | Buy |
+42,000
| New | +$1.14M | 0.07% | 239 |
|